Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118504) titled 'A Single-Arm, Prospective Clinical Study of Hypofractionated Thoracic Radiotherapy Combined with Adebrelimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small-Cell Lung Cancer' on Feb. 6.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: HenanCancerHospital
Condition:
Extensive-Stage Small-Cell Lung Cancer
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-03-01
Target Sample Size: Experimental Group:60;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=303350
Published by HT Digital Co...